Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

NVAX Novavax Inc

4,089

0,139 (3,52%)

27 Apr 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Novavax (NASDAQ:NVAX)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Novavax Charts.

Novavax (NASDAQ:NVAX)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Novavax Charts.

News Novavax Inc

Shah Capital nominates two highly qualified independent director candidates for Novavax
Montag 15 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Montag 1 April 2024 (4 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
Donnerstag 29 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Mittwoch 28 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 28 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Goldman Sachs Reconsiders Fed Cuts, LUNR Surges Over 40% in Pre-Market, and More
Freitag 23 Februar 2024 (2 Monate vor) • IH Market News

Form 8-K - Current report
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Donnerstag 22 Februar 2024 (2 Monate vor) • PR Newswire (US)

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
Dienstag 20 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Mittwoch 31 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Novavax Inc News-Artikel

BNP Paribas (QX)

Energy Select Sector SPDR

Euro vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen